{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:06:49Z","timestamp":1791184009102,"version":"4.1.0"},"reference-count":42,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2005,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>To reduce the biothreat posed by anthrax, efforts are under way to improve the protection afforded by vaccination. This work examines the ability of immunostimulatory CpG oligodeoxynucleotides (ODN) adsorbed onto cationic polylactide-co-glycolide (PLG) microparticles (CpG ODN-PLG) to accelerate and boost the protective immunity elicited by Anthrax Vaccine Adsorbed (AVA, the licensed human anthrax vaccine). The results indicate that coadministering CpG ODN-PLG with AVA induces a stronger and faster immunoglobulin G response against the protective antigen of anthrax than AVA alone. Immunized mice were protected from lethal anthrax challenge within 1 week of vaccination with CpG ODN-PLG plus AVA, with the level of protection correlating with serum immunoglobulin G anti-protective antigen titers.<\/jats:p>","DOI":"10.1128\/iai.73.2.828-833.2005","type":"journal-article","created":{"date-parts":[[2005,1,20]],"date-time":"2005-01-20T21:03:07Z","timestamp":1106254987000},"page":"828-833","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":90,"title":["CpG Oligodeoxynucleotides Adsorbed onto Polylactide-Co-Glycolide Microparticles Improve the Immunogenicity and Protective Activity of the Licensed Anthrax Vaccine"],"prefix":"10.1128","volume":"73","author":[{"given":"Hang","family":"Xie","sequence":"first","affiliation":[{"name":"Section of Retroviral Immunology, Center for Biologics Evaluation Research, Food and Drug Administration, Bethesda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihsan","family":"Gursel","sequence":"additional","affiliation":[{"name":"Section of Retroviral Immunology, Center for Biologics Evaluation Research, Food and Drug Administration, Bethesda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Ivins","sequence":"additional","affiliation":[{"name":"Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manmohan","family":"Singh","sequence":"additional","affiliation":[{"name":"Chiron Vaccines, Emeryville, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek T.","family":"O'Hagan","sequence":"additional","affiliation":[{"name":"Chiron Vaccines, Emeryville, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Ulmer","sequence":"additional","affiliation":[{"name":"Chiron Vaccines, Emeryville, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis M.","family":"Klinman","sequence":"additional","affiliation":[{"name":"Section of Retroviral Immunology, Center for Biologics Evaluation Research, Food and Drug Administration, Bethesda"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.2307\/2533072"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4049\/jimmunol.157.5.1840","volume":"157","year":"1996","unstructured":"Ballas, Z. D., W. L. Rasmussen, and A. M. Krieg. 1996. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol.157:1840-1847.","journal-title":"J. Immunol."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011053931523"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00443-0"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4049\/jimmunol.160.2.870","volume":"160","year":"1998","unstructured":"Davis, H. L., R. Weeranta, T. J. Waldschmidt, L. Tygrett, J. Schorr, and A. M. Krieg. 1998. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol.160:870-876.","journal-title":"J. Immunol."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301347"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2003.09.003"},{"key":"e_1_3_2_9_2","first-page":"729","year":"1998","unstructured":"Friedlander, A. M., and P. S. Brachman. 1998. Anthrax, p. 729-739. In S. A. Plotkin and E. A. Mortimer (ed.), Vaccines. W. B. Saunders, Philadelphia, Pa.","journal-title":"Vaccines"},{"key":"e_1_3_2_10_2","first-page":"217","volume":"20","year":"2002","unstructured":"Geier, D. A., and M. R. Geier. 2002. Anthrax vaccination and joint related adverse reactions in light of biological warfare scenarios. Clin. Exp. Rheumatol.20:217-220.","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.6.3324"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00045-8"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1996.0009"},{"key":"e_1_3_2_14_2","first-page":"13","volume":"225","year":"1998","unstructured":"Hanna, P. 1998. Anthrax pathogenesis and host response. Curr. Top. Microbiol. Immunol.225:13-35.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm987"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)80112-6"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00152686"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.58.2.303-308.1990"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.2.662-668.1992"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00145-0"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1329"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.12.020"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00151-0"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.7.2879"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/374546a0"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1201-1271"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(99)80004-5"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.07.004"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.19.9037-9043.2001"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/165.1.34"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00387-5"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00462-5"},{"key":"e_1_3_2_33_2","first-page":"799","year":"1998","unstructured":"Quinn, C. P., and P. C. Turnbull. 1998 Anthrax, p. 799-818. In M. Ballow and M. Sussman (ed.), Topley and Wilson's microbiology and microbial infections Collier, London, England.","journal-title":"Topley and Wilson's microbiology and microbial infections"},{"key":"e_1_3_2_34_2","first-page":"112","volume":"10","year":"2004","unstructured":"Ready, T. 2004. US soldiers refuse to fall in line with anthrax vaccination scheme. Nat. Med.10:112.","journal-title":"Nat. Med."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.46.27920"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.4.4.483"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00225-9"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012269226066"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(01)00167-3"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1462-5822.2003.00318.x"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.4.1659"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-147-6-1677"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0882-4010(88)90015-0"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.73.2.828-833.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.73.2.828-833.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T15:08:22Z","timestamp":1682953702000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.73.2.828-833.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["10.1128\/IAI.73.2.828-833.2005"],"URL":"https:\/\/doi.org\/10.1128\/iai.73.2.828-833.2005","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"2004-08-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-10-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}